<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>AMINOHIPPURATE SODIUMÂ PAH- aminohippurate sodiumÂ injection, solutionÂ </strong><br>Merck Sharp &amp; Dohme Corp.<br></p></div>
<h1>AMINOHIPPURATE SODIUM â€œPAHâ€?<br>INJECTION</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="i4i_description_id_8a5e116f-4bca-40f9-83d3-4fb1dd899e9b"></a><a name="section-1"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Aminohippurate sodium<a name="footnote-reference-1" href="#footnote-1" class="Sup">1</a> is an agent to measure effective renal plasma flow (ERPF). It is the sodium salt of para-aminohippuric acid, commonly abbreviated â€œPAHâ€?. It is water soluble, lipid-insoluble, and has a pKa of 3.83. The empirical formula of the anhydrous salt is C<span class="Sub">9</span>H<span class="Sub">9</span>N<span class="Sub">2</span>NaO<span class="Sub">3</span> and its structural formula is:</p>
<div class="Figure"><img alt="Image of Chemical Structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=a1975215-25f1-4c5a-878d-bcbf5326bb92&amp;name=0dc6d7ff-27f3-44ad-ac61-d0bbb0635d14-01.jpg"></div>
<p>It is provided as a sterile, non-preserved 20 percent aqueous solution for injection, with a pH of 6.7 to 7.6. Each 10 mL contains: Aminohippurate sodium 2 g. Inactive ingredients: Sodium hydroxide to adjust pH, water for injection, q.s. </p>
<hr class="Footnoterule">
<dl class="Footnote">
<dt><a name="footnote-1" href="#footnote-reference-1">1</a></dt>
<dd><p class="First">Formerly referred to as Sodium para-Aminohippurate.<br></p></dd>
</dl>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="i4i_clinical_pharmacology_id_230afbee-7ecb-4ef9-b104-3e8288ca6df4"></a><a name="section-2"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">PAH is filtered by the glomeruli and is actively secreted by the proximal tubules. At low plasma concentrations (1.0 to 2.0 mg/100 mL), an average of 90 percent of PAH is cleared by the kidneys from the renal blood stream in a single circulation. It is ideally suited for measurement of ERPF since it has a high clearance, is essentially nontoxic at the plasma concentrations reached with recommended doses, and its analytical determination is relatively simple and accurate.</p>
<p>PAH is also used to measure the functional capacity of the renal tubular secretory mechanism or transport maximum (Tm<span class="Sub">PAH</span>). This is accomplished by elevating the plasma concentration to levels (40-60 mg/100 mL) sufficient to saturate the maximal capacity of the tubular cells to secrete PAH.</p>
<p>Inulin clearance is generally measured during Tm<span class="Sub">PAH</span> determinations since glomerular filtration rate (GFR) must be known before calculations of secretory Tm measurements can be done (see <a href="#i4i_section_id_calculations">DOSAGE AND ADMINISTRATION, Calculations</a>).</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="i4i_indications_id_65d55df8-cc19-44e0-a3b8-42c6fe2550ec"></a><a name="section-3"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">Estimation of effective renal plasma flow.</p>
<p>Measurement of the functional capacity of the renal tubular secretory mechanism.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="i4i_contraindications_id_1600b20a-0304-4139-959d-d589a313d5a4"></a><a name="section-4"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First"><span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Hypersensitivity</span> to this product or to its components.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="i4i_precautions_id_ac1f5fda-7b8d-46fa-b5df-55efb5a11bbe"></a><a name="section-5"></a><p></p>
<h1>PRECAUTIONS</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="i4i_precautions_general_id_eddfa1b9-537f-4d70-8ef6-ef562f8680d2"></a><a name="section-5.1"></a><p></p>
<h2>General</h2>
<p class="First">Intravenous solutions must be given with caution to patients with low cardiac reserve, since a rapid increase in plasma volume can precipitate <span class="product-label-link" type="condition" conceptid="319835" conceptname="Congestive heart failure">congestive heart failure</span>.</p>
<p>For measurement of ERPF, small doses of PAH are used. However, in research procedures to measure Tm<span class="Sub">PAH</span>, high plasma levels are required to saturate the capacity of the tubular cells. During these procedures, the intravenous administration of PAH solutions should be carried out slowly and with caution. The patient should be continuously observed for any adverse reactions.</p>
<p>Use caution when injecting this product into latex-sensitive individuals, since the vial stopper contains dry natural latex rubber that may cause <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergic reactions</span>.</p>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="i4i_interactions_id_092668ae-b300-4452-978f-adc232b81112"></a><a name="section-5.2"></a><p></p>
<h2>Drug Interactions</h2>
<p class="First">Renal clearance measurements of PAH cannot be made with any significant accuracy in patients receiving sulfonamides, procaine, or thiazolesulfone. These compounds interfere with chemical color development essential to the analytical procedures.</p>
<p>Probenecid depresses tubular secretion of certain weak acids such as PAH. Therefore, patients receiving probenecid will have erroneously low ERPF and Tm<span class="Sub">PAH</span> values.</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="i4i_carcinogenesis_mutagenesis_fertility_id_b691edd6-2016-458b-8414-8354ca6e6d1f"></a><a name="section-5.3"></a><p></p>
<h2>Carcinogenesis, Mutagenesis, Impairment of Fertility</h2>
<p class="First">Long-term studies in animals have not been done to evaluate any effects upon fertility or carcinogenic potential of PAH.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="i4i_pregnancy_id_13ee97cb-5ef8-46ae-b3f8-38267952dca3"></a><a name="section-5.4"></a><p></p>
<h2>Pregnancy</h2>
<div class="Section" data-sectionCode="34077-8">
<a name="i4i_teratogenic_id_46f54381-3ca3-4ba7-b58f-349b7e1aceff"></a><a name="section-5.4.1"></a><p></p>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_433edf1a-8fd2-468c-a7f1-5436924ae0a8"></a><a name="section-5.4.1.1"></a><p></p>
<h4>Pregnancy Category C</h4>
<p class="First">Animal reproduction studies have not been done with PAH. It is also not known whether PAH can cause fetal harm when given to a pregnant woman or can affect reproduction capacity. PAH should be given to a pregnant woman only if clearly needed.</p>
</div>
</div>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="i4i_nursing_mothers_id_29d431c4-048e-4b00-b492-2378a86a44e5"></a><a name="section-5.5"></a><p></p>
<h2>Nursing Mothers</h2>
<p class="First">It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when PAH is administered to a nursing woman.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="i4i_pediatric_use_id_3286f36c-e732-48d3-a1b9-4b0a8babe507"></a><a name="section-5.6"></a><p></p>
<h2>Pediatric Use</h2>
<p class="First">Safety and effectiveness in pediatric patients have not been established.</p>
</div>
<div class="Section" data-sectionCode="34082-8">
<a name="i4i_geriatric_use_id_6578889a-99cc-495a-9367-482f94d0bfc9"></a><a name="section-5.7"></a><p></p>
<h2>Geriatric Use</h2>
<p class="First">Clinical studies of PAH did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="i4i_adverse_effects_id_b969e15a-a244-481a-9101-06dd875a1d60"></a><a name="section-6"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First"><span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Hypersensitivity reactions</span> including <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylaxis</span>, <span class="product-label-link" type="condition" conceptid="432791" conceptname="Angioedema">angioedema</span>, <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span>, vasomotor disturbances, <span class="product-label-link" type="condition" conceptid="318566" conceptname="Flushing">flushing</span>, <span class="product-label-link" type="condition" conceptid="4193492" conceptname="Acroparesthesia">tingling</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, and <span class="product-label-link" type="condition" conceptid="75635" conceptname="Cramp">cramps</span> may occur.</p>
<p>Patients may have a <span class="product-label-link" type="condition" conceptid="4141161" conceptname="Hot">sensation of warmth</span> or the desire to defecate or urinate during or shortly following initiation of infusion.</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="i4i_overdosage_id_a4fcfb15-ad6b-40be-bf1f-288378e4e0af"></a><a name="section-7"></a><p></p>
<h1><span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">OVERDOSE</span></h1>
<p class="First">The intravenous LD<span class="Sub">50</span> in female mice is 7.22 g/kg.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="i4i_dosage_admin_id_813e1a9f-9d1d-4aab-a236-68846e3b6c8a"></a><a name="section-8"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First"><span class="Italics">For intravenous use only</span></p>
<p>Clearance measurements using single injection techniques are generally inaccurate, particularly in the measurement of ERPF. For this reason, intravenous infusions at fixed rates are used to sustain the plasma PAH concentration at the desired level.</p>
<p>To measure ERPF, the concentration of PAH in the plasma should be maintained at 2 mg per 100 mL, which can be achieved with a priming dose of 6 to 10 mg/kg and an infusion dose of 10 to 24 mg/min.</p>
<p>As a research procedure for the measurement of Tm<span class="Sub">PAH</span>, the plasma level of PAH must be sufficient to saturate the capacity of the tubular secretory cells. Concentrations from 40 to 60 mg per 100 mL are usually necessary.</p>
<p>Technical details of these tests may be found in Smith <a href="#i4i_references_id_references">{1}</a>; Wesson <a href="#i4i_references_id_references">{2}</a>; Bauer <a href="#i4i_references_id_references">{3}</a>; Pitts<a href="#i4i_references_id_references">{4}</a>; and Schnurr <a href="#i4i_references_id_references">{5}</a>.</p>
<p>Parenteral drug products should be inspected visually for particulate matter and discoloration prior to use, whenever solution and container permit. NOTE: The normal color range for this product is a colorless to yellow/brown solution. The efficacy is not affected by color changes within this range.</p>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_calculations"></a><a name="section-8.1"></a><p></p>
<h2><span class="Underline">Calculations</span></h2>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_ee9355f4-3f18-4dcf-a5f1-5d32f050d6f9"></a><a name="section-8.1.1"></a><p></p>
<h3><span class="Italics">Effective Renal Plasma Flow (ERPF)</span></h3>
<p class="First">The clearance of PAH, which is extracted almost completely from the plasma during its passage through the renal circulation, constitutes a measure of ERPF. Hence:</p>
<p>ERPF = U<span class="Sub">PAH</span>V/P<span class="Sub">PAH</span></p>
<p>Where U<span class="Sub">PAH</span> = concentration of PAH (mg/mL) in the urine</p>
<p>V = rate of urine excretion (mL/min), and</p>
<p>P<span class="Sub">PAH</span> = plasma concentration of PAH (mg/mL).</p>
<p>Example: </p>
<p>U<span class="Sub">PAH</span> = 8.0 mg/mL</p>
<p>V = 1.5 mL/min</p>
<p>P<span class="Sub">PAH</span> = 0.02 mg/mL</p>
<p>ERPF = 8.0 x 1.5/0.02 = 600 mL/min</p>
<p>Based on PAH clearance studies, the normal values for ERPF are:</p>
<p>men 675 Â± 150 mL/min</p>
<p>women 595 Â± 125 mL/min</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_40c2ba45-5458-4de9-8bac-3d423afbc754"></a><a name="section-8.1.2"></a><p></p>
<h3>
<span class="Italics">Maximum Tubular Secretory <br>(Tm<span class="Sub">PAH </span>) Mechanism</span>Â </h3>
<p class="First">The quantity of PAH secreted by the tubules (Tm<span class="Sub">PAH</span>) is given by the difference between the total rate of excretion (U<span class="Sub">PAH</span>V) and the quantity filtered by the glomeruli (GFR x P<span class="Sub">PAH</span>). Hence:</p>
<p>Tm<span class="Sub">PAH</span> = U<span class="Sub">PAH</span>V â€“ (GFR x P<span class="Sub">PAH</span> x 0.83)</p>
<p>The factor, 0.83, corrects for that portion of PAH which is bound to plasma protein and hence is unfilterable.</p>
<p>Example:</p>
<p>U<span class="Sub">PAH</span> = 9.55 mg/mL</p>
<p>V = 16.68 mL/min</p>
<p>GFR = 120 mL/min</p>
<p>P<span class="Sub">PAH</span> = 0.60 mg/mL</p>
<p>Then Tm<span class="Sub">PAH</span> = 9.55 x 16.68 â€“ (120 x 0.60 x 0.83) = 100 mg/min.</p>
<p>Average normal values of Tm<span class="Sub">PAH</span> are 80-90 mg/min.</p>
<p>The value of the expression U<span class="Sub">PAH</span>V, used in calculations of ERPF and Tm<span class="Sub">PAH</span>, may be found by determining the amount of PAH in a measured volume of urine excreted within a specific period of time.</p>
<p>These calculations are based on a body surface area of 1.73 m<span class="Sup">2</span>. Corrections for variations in surface area are made by multiplying the values obtained for ERPF and Tm<span class="Sub">PAH</span> by 1.73/A, where A is the subject surface area.</p>
</div>
</div>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="i4i_how_supplied_id_1e5be705-8c47-471e-89e9-5529288aa3ae"></a><a name="section-9"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">No. 95 â€” Aminohippurate Sodium, 20 percent sterile solution for intravenous injection, is supplied as follows:</p>
<p><span class="Bold"><span class="Emphasis">NDC</span></span> 0006-3395-11 in 10 mL vials.</p>
<div class="Section" data-sectionCode="44425-7">
<a name="i4i_storage_id_a70d3418-d46b-4547-aaca-a1880ba317fa"></a><a name="section-9.1"></a><p></p>
<h2>Storage</h2>
<p class="First">Store at 25Â°C (77Â°F); excursions permitted to 15-30Â°C (59-86Â°F) [see USP Controlled Room Temperature].</p>
</div>
</div>
<div class="Section" data-sectionCode="34093-5">
<a name="i4i_references_id_references"></a><a name="section-10"></a><p></p>
<h1>REFERENCES</h1>
<ol>
<li>Smith, H.W.: Lectures on the kidney, University Extension Division, University of Kansas, Lawrence, Kansas, 1943.</li>
<li>Wesson, L.G., Jr.: "Physiology of the Human Kidney," New York, Grune &amp; Stratton, 1969, pp. 632-655.</li>
<li>Bauer, J.D.; Ackermann, P.G.; Toro, G.: "Brays Clinical Laboratory Methods," ed. 7, St. Louis, Mosby, 1968.</li>
<li>Pitts, R.F.: "Physiology of the Kidney and Body Fluids," ed. 2, Chicago, Year Book Medical Publishers, 1968.</li>
<li>Schnurr, E.; Lahme, W.; Kuppers, H.: Measurement of renal clearance of inulin and PAH in the steady state without urine collection; Clinical Nephrology, <span class="Italics">13</span>(1): (26-29), 1980.</li>
</ol>
<p class="First">Merck Sharp &amp; Dohme Corp., a subsidiary of<br><span class="Bold">MERCK &amp; CO., INC.,</span> Whitehouse Station, NJ 08889, USA</p>
<p>Issued January 2011</p>
<p>Printed in USA</p>
<p>9051026</p>
<p>Copyright Â© 1983 Merck Sharp &amp; Dohme Corp., a subsidiary of <span class="Bold">Merck &amp; Co., Inc.</span><br>All rights reserved</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="i4i_Principal_display_panel_id_33b0f73e-4fd5-4b83-be70-430d133e6ef3"></a><a name="section-11"></a><p></p>
<h1> This is a representative sample of the packaging. Please see How Supplied section for a complete list of available packaging.<br><br>PRINCIPAL DISPLAY PANEL - Carton - 10 mL Single Dose Vial</h1>
<p class="First">NDC 0006-3395-11</p>
<p> SINGLE DOSE VIAL <br>10 mL INJECTION</p>
<p> AMINOHIPPURATE Sodium </p>
<p> 2 g in 10 mL<br>(20% solution) </p>
<p> FOR INTRAVENOUS USE ONLY TO DETERMINE KIDNEY FUNCTION </p>
<p> Rx only </p>
<p> Merck Sharp &amp; Dohme Corp.,<br>a subsidiary of <br>MERCK &amp; CO., INC. <br>Whitehouse Station, NJ 08889, USA</p>
<div class="Figure"><img alt="PRINCIPAL DISPLAY PANEL - Carton - 10 mL Single Dose Vial" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=a1975215-25f1-4c5a-878d-bcbf5326bb92&amp;name=0dc6d7ff-27f3-44ad-ac61-d0bbb0635d14-02.jpg"></div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>AMINOHIPPURATE SODIUMÂ 		
					PAH</strong><br><span class="contentTableReg">aminohippurate sodium injection, solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0006-3395</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAVENOUS</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>AMINOHIPPURATE SODIUM</strong> (AMINOHIPPURIC ACID) </td>
<td class="formItem">AMINOHIPPURATE SODIUM</td>
<td class="formItem">2Â g Â inÂ 10Â mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SODIUM HYDROXIDE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">YELLOW,Â BROWN (colorless to yellow/brown) </td>
<td class="formLabel">Score</td>
<td class="formItem">Â Â Â Â </td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem"></td>
<td class="formLabel">Size</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">Â Â Â Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0006-3395-11</td>
<td class="formItem">1  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">10 mL in 1 VIAL, SINGLE-DOSE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA005619</td>
<td class="formItem">12/30/1944</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler -Â </span>Merck Sharp &amp; Dohme Corp.
							(001317064)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Merck Sharp &amp; Dohme Corp.</td>
<td class="formItem"></td>
<td class="formItem">002387926</td>
<td class="formItem">MANUFACTURE</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 1/2011<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>0dc6d7ff-27f3-44ad-ac61-d0bbb0635d14</div>
<div>Set id: a1975215-25f1-4c5a-878d-bcbf5326bb92</div>
<div>Version: 7</div>
<div>Effective Time: 20110119</div>
</div>
</div>Â <div class="DistributorName">Merck Sharp &amp; Dohme Corp.</div></p>
</body></html>
